Pfizer
'When I grow up, I want to be like you': remembering Morris Kahn's most productive years - opinion
Founder of the Genesis Prize Stan Polovets on why your seventies and eighties – and even nineties – can be your most impactful years.
Grapevine, November 30, 2025: Mamdani complexities
MBS’s first Washington trip since 2018 brings new investments
Former Pfizer chief scientist joins Immunai’s board of directors
Pfizer vaccine for children under 5 may be available in US by end of Feb
COVID vaccines for children younger than 5 could be available as soon as the end of February under a plan that would lead to the authorization of a two-shot regimen.
Omicron: UKHSA finds boosters provide 95% protection against death
For Moderna, effectiveness against hospitalization was 90-95% up to 9 weeks after the booster.
Pfizer CEO Albert Bourla, son of Holocaust survivors, is working to preserve Jewish history
The Pfizer-BioNTech COVID-19 vaccine was the first to be authorized by the FDA for emergency use in December 2020. It's also the vaccine that Israel has given to its citizens.
Sputnik V shows higher Omicron-antibody levels than Pfizer - study
A joint Russian-Italian study compared the blood serum of people who had received the different vaccines.
Pfizer CEO awarded Genesis Prize for efforts to combat COVID-19
The $1 million Genesis Prize, launched in 2013, honors extraordinary people for their professional achievements. Dr. Albert Bourla was chosen as this year's Genesis Prize Laureate.
COVID-19: 92% of patients treated with Pfizer antiviral improved
Of the individuals who received Paxlovid, 60% started to feel better within the first day, a survey by the second largest healthcare provider in Israel showed.
Pfizer CEO: COVID-19 will continue to circulate for many years
Bourla along with Moderna CEO Stéphane Bancel said last week that they are preparing a booster that will treat the newly-introduced Omicron variant.
COVID-19 isolation to be shortened to five days
Some 27,167 people tested positive for COVID-19 on Saturday, and serious cases rose from 387 to 436.
Africa CDC talking to Pfizer about importing its COVID treatment pill
Governments around the world are scrambling to buy Paxlovid, while Merck's Molnupiravir has faced setbacks after disappointing trial data.
COVID-19: Pfizer and Moderna prepare vaccine against Omicron
The CEOs of Pfizer and Moderna say they are preparing a booster targeting Omicron. Pfizer CEO Albert Bourla is still unsure if there is a need for the fourth booster.
